FSHD Life Expectancy: Will It Shorten My Life?
At a Glance
Facioscapulohumeral dystrophy (FSHD) does not typically shorten your life expectancy. Unlike other muscular dystrophies, FSHD rarely causes life-threatening heart or breathing complications, allowing the vast majority of patients to live a full, normal lifespan.
Facioscapulohumeral dystrophy (FSHD) typically does not affect normal life expectancy [1]. If you have just been diagnosed, it is completely normal to be concerned about your future, but you can be reassured that the vast majority of people with this condition live a full, normal lifespan.
Unlike some other forms of muscular dystrophy, FSHD rarely causes severe weakness in the heart muscle or the diaphragm (the main muscle used for breathing). These are the complications that most often shorten the lives of people with other muscle diseases, but they are not the typical path for FSHD.
Why FSHD is Different
When you read about muscular dystrophy, you may encounter frightening statistics about heart and lung failure. It is important to know that FSHD affects the body differently than conditions like Duchenne muscular dystrophy.
Your Heart Muscle is Usually Spared
Many people diagnosed with a muscular dystrophy immediately worry about their heart. In FSHD, the heart muscle remains strong in the vast majority of cases. While doctors may find minor electrical irregularities—such as a right bundle branch block (a slight delay in the electrical signals that tell the heart to beat)—these are typically mild and rarely life-threatening [2][3]. Severe cardiomyopathy (dangerous weakening of the heart muscle) is not a standard feature of FSHD.
Just as with your breathing, the standard of care is to play it safe. Your doctor will likely recommend a baseline electrocardiogram (EKG) at the time of your diagnosis to check for these minor electrical issues and establish a healthy baseline [4].
Breathing Issues Are Rare but Monitored
Severe respiratory involvement in FSHD is uncommon [1]. When breathing issues do occur, they usually develop only in individuals who have more advanced disease, such as those who:
- Have significant kyphoscoliosis (an abnormal curvature of the spine) [5]
- Depend on a wheelchair for mobility [5]
Even though life-threatening breathing problems are rare, medical teams take no chances. You should expect to receive a baseline breathing test (pulmonary function test) when you are first diagnosed [1]. If you ever require a wheelchair, develop spinal curvature, or have moderate weakness, your doctor will monitor your breathing regularly to be safe [4]. If breathing support is ever needed, it is typically managed with non-invasive ventilation, such as wearing a specialized mask while you sleep.
Focusing on Quality of Life
Because FSHD does not typically shorten your lifespan [1], your medical care will be heavily focused on what matters most: your daily quality of life. The progression of FSHD is highly variable; not everyone experiences severe weakness, and only a minority of individuals ever require a wheelchair.
Instead of focusing on life-threatening complications, your energy and medical care will center on managing the hallmark symptoms of the condition—weakness in the face, shoulders, and arms. By partnering with a neurologist or a neuromuscular specialist, you can proactively manage pain, maintain mobility, and concentrate on living well.
Common questions in this guide
Does FSHD shorten your life expectancy?
Can FSHD cause heart problems?
Will I have trouble breathing with FSHD?
What baseline tests do I need after an FSHD diagnosis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Should I schedule a baseline EKG and pulmonary function test now that I am diagnosed?
- 2.How often will we monitor my breathing and heart function going forward?
- 3.If I experience symptoms like morning headaches, daytime sleepiness, or shortness of breath when lying flat, how quickly should I contact your office?
- 4.Can you refer me to a physical therapist who has specific experience with FSHD?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (5)
- 1
Respiratory function and evaluation in individuals with facioscapulohumeral muscular dystrophy in the Muscular Dystrophy Surveillance, Tracking and Research Network.
Mathews KD, Suhl J, Conway KM, et al.
Neuromuscular disorders : NMD 2025; (46()):105240 doi:10.1016/j.nmd.2024.105240.
PMID: 39579597 - 2
Cardiac Abnormalities in Type 1 Facioscapulohumeral Muscular Dystrophy.
Labombarda F, Maurice M, Simon JP, et al.
Journal of clinical neuromuscular disease 2017; (18(4)):199-206 doi:10.1097/CND.0000000000000144.
PMID: 28538250 - 3
Evaluation of Myocardial Strain by 2-Dimensional Speckle Tracking Echocardiography in Patients with Facioscapulohumeral Muscular Dystrophy.
Işık F, Akyüz A, Çap M, et al.
Anatolian journal of cardiology 2022; (26(7)):525-531 doi:10.5152/AnatolJCardiol.2022.907.
PMID: 35791708 - 4
Muscular Dystrophies.
Chen YW, Bittel AJ, Bittel DC, et al.
Advances in experimental medicine and biology 2025; (1478()):245-284 doi:10.1007/978-3-031-88361-3_11.
PMID: 40879943 - 5
Respiratory function in facioscapulohumeral muscular dystrophy 1.
Wohlgemuth M, Horlings CGC, van der Kooi EL, et al.
Neuromuscular disorders : NMD 2017; (27(6)):526-530 doi:10.1016/j.nmd.2017.03.008.
PMID: 28416348
This page provides educational information about FSHD life expectancy and disease progression. It is for informational purposes only and does not replace professional medical advice from your neurologist or care team.
Get notified when new evidence is published on Facioscapulohumeral dystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.